Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual thrombolytic therapy with HisproUK and low-dose alteplase for acute ischemic stroke
NL-OMON29554Phase 2Recruiting
- Sponsor
- Erasmus MC
- Start
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of tissue-plasminogen activator, mutant pro-urokinase in ischemic stroke, sponsored by Erasmus MC. Started Aug 2019; status: recruiting.
02
Drugs
tissue-plasminogen activatormutant pro-urokinase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NL-OMON29554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29554.